Financial Top 5 Things markets attempted to claw back on Tuesday after the steepest worldwide selloff in two years as worries over the economic fallout from the coronavirus crisis hit fever pitch. Wall Street futures pared early gains despite reports of a possible vaccine and European markets gave back early gains as the virus spread in Italy. Bets on a Federal Reserve rate cut have risen, and the corporate cost of the crisis mounted as more companies warned of slowing revenue growth. Meanwhile, OPEC insisted it hasn’t run out of options to rebalance oil markets as prices remain under pressure. Here’s what you need to know to start your day.
- Turnaround Tuesday?
U.S. stock futures pointed to a flat open on Wall Street by 7:18 AM ET (1218 GMT), with Dow futures reversing a more than 100 point gain. The Dow shed more than 1,000 points by the close on Monday, its third-largest points decline ever amid a global stock selloff triggered by fears over the damage a pandemic would do to the global economy.
Top 5 Things
The S&P 500 ended down 3.3%, also the worst drop in two years. With Monday’s declines, the S&P 500 and the Dow both wiped out their gains for the year to date.
A Wall Street Journal report on a possible vaccine was cited as helping sentiment, but European markets fell back into the red, surrendering early gains as the virus spread to the south of Italy and Spanish authorities tested hundreds of tourists in the Canary Islands hotel after a case was identified.
- 80,000 people globally hit by virus
The coronavirus outbreak has now affected 80,000 people globally and the death toll in Italy climbed to seven on Monday with 229 cases reported in what is the largest cluster of virus cases in Europe.
China reported a rise in new cases in Hubei province, the epicenter of the outbreak, even though the rest of the country saw a fourth-straight day of declines.
South Korea, which has the most virus cases in Asia outside China, reported 60 new cases on Tuesday, increasing the total number of infected patients there to almost 900.
The WSJ reported that drugmaker Moderna (NASDAQ: MRNA) has shipped the first batch of its rapidly developed coronavirus vaccine to U.S. government researchers to be tested in humans. Shares in the company soared 15.6% to $21.33 in after-hours trading on Monday.
Separately, China is planning to release results from clinical trials of a Gilead Sciences (NASDAQ :GILD) drug in April.
The difference between a suitability assessment and a sustainability assessment
The difference between a suitability assessment and a sustainability assessment in a project feasibility study A feasibility study consists of several key points
It greatly helps in the success of this study, as all steps must be implemented and none of them should be ignored
This is because they work in a circular motion, which are rings that complement each other and help in the success of the project when one of the links is lost
This leads to an imbalance and the inability to implement the feasibility study at the same level of feasibility required,
So in this article, we will explain to you what is the difference between a suitability assessment and a sustainability assessment in a project feasibility study.